Literature DB >> 31240697

Circular RNAs: A novel biomarker for cervical cancer.

Shala Chaichian1,2, Rana Shafabakhsh3, Seyyed Mehdi Mirhashemi4, Bahram Moazzami2, Zatollah Asemi3.   

Abstract

Besides messenger RNAs, recent RNA-Seq and biochemical analysis showed another type of RNAs as a product of splicing which is named circular RNA (circRNA). Evidence demonstrated that circRNAs are abundant in the cells and are able to show cell/tissue-specific expression or tissue developmental stage which suggest that circRNAs may have regulatory potentials. In recent years, researchers have focused attention on circRNAs because of their key functions in various cellular mechanisms. CircRNAs also have the potential to be as promising biomarkers for diagnosis of various diseases such as cancer. Growing up evidence has shown the various roles of circRNAs in multiple cancers. In recent years, cervical cancer as one of the main causes of cancer death in women has been interesting for molecular research. CircRNAs are one of the novel objects which have recently been evaluated in this cancer. The improvement in our knowledge of the roles of circRNAs in cervical cancer may lead to new transcription therapeutic approaches to cervical cancer inhibition. Therefore, the purpose of this review is to review many studies which examined the role of circRNAs in cervical cancer carcinogenesis and progression up till date and to summarize possible mechanisms of action of circRNAs in cervical neoplasm.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical cancer; circRNAs; genetic alterations

Year:  2019        PMID: 31240697     DOI: 10.1002/jcp.29009

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  45 in total

Review 1.  Circular RNA in osteoarthritis: an updated insight into the pathophysiology and therapeutics.

Authors:  Di Liu; Yin-Hua Liang; Yun-Tao Yang; Miao He; Zi-Jun Cai; Wen-Feng Xiao; Yu-Sheng Li
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  CircWHSC1 expedites cervical cancer progression via miR-532-3p/LTBP2 axis.

Authors:  Yan Li; Fandong Meng; Chengguang Sui; Yang Wang; Dali Cheng
Journal:  Mol Cell Biochem       Date:  2022-03-02       Impact factor: 3.396

3.  CircRNA-PTPRA Knockdown Inhibits Atherosclerosis Progression by Repressing ox-LDL-Induced Endothelial Cell Injury via Sponging of miR-671-5p.

Authors:  Xueting Luo; Xiaoli Zhou
Journal:  Biochem Genet       Date:  2022-07-11       Impact factor: 2.220

4.  Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).

Authors:  Siwei Li; Heng Zhang; Yunping Jiao; Xiao Song; Lei Wei; Xing Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer.

Authors:  Yan-Long Shi; Ming-Bo Liu; Hong-Ting Wu; Ye Han; Xuan He
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

Review 6.  Mobius strip in pancreatic cancer: biogenesis, function and clinical significance of circular RNAs.

Authors:  Bangbo Zhao; Zeru Li; Cheng Qin; Tianhao Li; Yuanyang Wang; Hongtao Cao; Xiaoying Yang; Weibin Wang
Journal:  Cell Mol Life Sci       Date:  2021-08-03       Impact factor: 9.261

7.  hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.

Authors:  Yumei Lv; Mingyi Wang; Mingli Chen; Dan Wang; Mingyan Luo; Qingyuan Zeng
Journal:  J Clin Lab Anal       Date:  2022-03-11       Impact factor: 2.352

8.  Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2.

Authors:  Fenghua Zhang; Yun Xu; Wenfeng Ye; Jingting Jiang; Changping Wu
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

9.  Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression Through Regulating miR-567/ZNF268 Axis.

Authors:  Zhilan Yao; Liuping Shu; Yi Yi; Lifu Qiao
Journal:  Cancer Manag Res       Date:  2021-06-30       Impact factor: 3.989

10.  hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.

Authors:  Xuezuo Sui; Yanchun Wang; Hui Liu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.